Clinical trial
A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
NCT02013791 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Multi-center, Vehicle- and Sham-controlled, Randomized Study of RESTASIS® X in Patients With Moderate to Severe Dry Eye Disease
- Lead sponsor
- Allergan
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- April 29, 2014
- Completion date
- April 12, 2017
- Enrollment
- 55 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.